
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®).

Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®).
Fecha de publicación: Enero 2019Valproic acid promotes a decrease in mycobacterial survival by enhancing nitric oxide production in macrophages...
Fecha de publicación: 8 noviembre 22 Altered neutrophil-to-lymphocyte ratio in sepsis secondary to canine parvoviral enteritis treated with and...
Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....
Fecha de publicación: 20 Septiembre 2019 Utilization of naproxen by Amycolatopsis sp. Poz 14 and detectionof the enzymes involved...
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS
Fecha de publicación: Septiembre 2019 A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced...
Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. VER MÁS
Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons. VER MÁS

+52 (55) 5729 6000 Ext. 62543
Escuela Nacional de Ciencias Biológicas. Prolongación de Carpio y Plan de Ayala S/N, Del. Miguel Hidalgo, CDMX, C.P. 11340.
©2026 UDIBI